• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 3. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides
• Other Chemical Reagents

Introduction to H-SER-GLU-OH and Its Significance in Modern Chemical Biology

H-SER-GLU-OH, a compound with the CAS number 6403-16-3, represents a critical molecule in the realm of chemical biology. This compound, characterized by its unique structural and functional properties, has garnered significant attention in recent years due to its potential applications in pharmaceutical research and therapeutic development. The name itself, H-SER-GLU-OH, provides valuable insights into its chemical composition, highlighting the presence of serine (SER), glutamic acid (GLU), and a hydroxyl (OH) group, which collectively contribute to its distinct biological activity.

The study of such compounds is increasingly relevant in the context of contemporary medical research. Recent advancements in the field have demonstrated that molecules like H-SER-GLU-OH can serve as potent scaffolds for drug design. Specifically, the incorporation of serine and glutamic acid residues into synthetic peptides has been shown to enhance binding affinity and specificity towards target proteins. This has opened up new avenues for the development of targeted therapies, particularly in the treatment of neurological disorders and inflammatory conditions.

One of the most compelling aspects of H-SER-GLU-OH is its role in modulating biological pathways. Serine and glutamic acid are both essential amino acids that play pivotal roles in various cellular processes. For instance, serine is involved in protein synthesis and signal transduction, while glutamic acid is a key neurotransmitter. The hydroxyl group in H-SER-GLU-OH further enhances its reactivity, allowing it to participate in a wide range of biochemical reactions. These properties make it an attractive candidate for use in drug discovery and development.

In recent years, there has been a surge in research focused on the development of novel peptidomimetics—molecules that mimic the structure and function of natural peptides but with improved stability and bioavailability. H-SER-GLU-OH fits well within this paradigm, as it can be modified to create peptidomimetic analogs with enhanced pharmacological properties. Such modifications have led to the discovery of several promising lead compounds that are currently undergoing preclinical evaluation.

The significance of H-SER-GLU-OH is further underscored by its potential applications in peptide-based therapeutics. Peptides have long been recognized for their therapeutic potential due to their ability to interact with biological targets with high specificity. However, their susceptibility to degradation by proteases has limited their clinical use. The incorporation of H-SER-GLU-OH into peptide sequences can help mitigate this issue by enhancing resistance to enzymatic degradation. This has led to the development of more stable and effective peptide-based drugs.

Another area where H-SER-GLU-OH has shown promise is in the field of immunotherapy. The ability of certain peptides to modulate immune responses has been extensively studied, and H-SER-GLU-OH-based compounds have emerged as potential immunomodulators. For instance, studies have demonstrated that peptides containing serine and glutamic acid residues can activate immune cells and enhance antitumor responses. These findings have opened up new possibilities for the development of immunotherapeutic strategies against cancer and other chronic diseases.

The synthesis and characterization of H-SER-GLU-OH have also benefited from advancements in synthetic chemistry. Modern techniques such as solid-phase peptide synthesis (SPPS) have made it possible to produce complex peptidomimetics with high efficiency and precision. Additionally, computational methods have been employed to predict the structural and functional properties of these molecules before they are synthesized experimentally. This has significantly reduced the time and cost associated with drug discovery.

Future directions in the study of H-SER-GLU-OH are likely to focus on expanding its therapeutic applications. Researchers are exploring ways to optimize its structure for better pharmacokinetic profiles and improved target specificity. Additionally, efforts are underway to develop novel delivery systems that can enhance the bioavailability of peptide-based drugs containing H-SER-GLU-OH.

In conclusion, H-SER-GLU-OH represents a fascinating compound with significant potential in chemical biology and pharmaceutical research. Its unique structural features and biological activities make it an attractive candidate for drug design and development. As our understanding of its mechanisms of action continues to grow, so too will its applications in medicine. The ongoing research into this compound underscores its importance as a tool for advancing therapeutic strategies against a wide range of diseases.

• 115633-61-9(L-Glutamic acid,N-(N-L-lysyl-L-seryl)-, homopolymer (9CI))
• 923584-96-7(L-Glutamic acid, L-seryl-L-a-glutamyl-L-seryl-L-lysyl-)
• 646502-52-5(L-Alanine, glycyl-L-seryl-L-glutaminyl-L-a-glutamylglycyl-L-seryl-)
• 918440-00-3(L-Glutamine, glycylglycylglycyl-L-seryl-L-seryl-L-glutaminyl-L-seryl-L-glutaminyl-L-seryl-)
• 100929-80-4(L-Glutamic acid,N-formyl-L-alanylglycyl-L-seryl- (9CI))
• 874769-05-8(L-Lysine, L-lysyl-L-seryl-L-lysyl-)
• 475390-92-2(L-GLUTAMIC ACID, L-ALANYL-L-LYSYL-L-LYSYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-)
• 130170-10-4(L-Lysine,N2-[N-[N-[N-(1-oxododecyl)glycyl]-L-seryl]-L-seryl]- (9CI))
• 61756-30-7(L-Glutamic acid, N-(N-glycyl-L-seryl)-)
• 61756-28-3(L-Glutamic acid,L-alanylglycyl-L-seryl-)